Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 8
2004 5
2005 11
2006 5
2007 8
2008 14
2009 7
2010 4
2011 13
2012 8
2013 12
2014 16
2015 20
2016 12
2017 13
2018 9
2019 5
2020 11
2021 13
2022 11
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy.
Abou Khouzam R, Janji B, Thiery J, Zaarour RF, Chamseddine AN, Mayr H, Savagner P, Kieda C, Gad S, Buart S, Lehn JM, Limani P, Chouaib S. Abou Khouzam R, et al. Among authors: chouaib s. Semin Cancer Biol. 2023 Dec;97:104-123. doi: 10.1016/j.semcancer.2023.11.008. Epub 2023 Nov 28. Semin Cancer Biol. 2023. PMID: 38029865 Review.
The roles of different forms of IL-15 in human melanoma progression.
Di Matteo S, Munari E, Fiore PF, Santopolo S, Sampaoli C, Pelosi A, Chouaib S, Tumino N, Vacca P, Mariotti FR, Ebert S, Machwirth M, Haas D, Pezzullo M, Pietra G, Grottoli M, Buart S, Mortier E, Maggi E, Moretta L, Caruana I, Azzarone B. Di Matteo S, et al. Among authors: chouaib s. Front Immunol. 2023 Jun 2;14:1183668. doi: 10.3389/fimmu.2023.1183668. eCollection 2023. Front Immunol. 2023. PMID: 37334356 Free PMC article.
Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies.
Mortara L, Benest AV, Derosa L, Chouaib S, Ribatti D. Mortara L, et al. Among authors: chouaib s. Front Immunol. 2022 Oct 6;13:1045074. doi: 10.3389/fimmu.2022.1045074. eCollection 2022. Front Immunol. 2022. PMID: 36275734 Free PMC article. No abstract available.
209 results